永顺生物
(920729)
| 流通市值：0.00万 | | | 总市值：0.00万 |
| 流通股本：0.00万 | | | 总股本：0.00万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 12,935,651.82 | 22,468,586.94 | 36,593,830.46 | 35,746,237.2 |
| 交易性金融资产 | 22,785,636.26 | 43,810,425.92 | 15,004,743.82 | - |
| 应收票据及应收账款 | 83,221,409.9 | 97,894,627.22 | 95,757,549.69 | 113,425,944.75 |
| 其中：应收票据 | 6,189,740.53 | 5,043,335.3 | 7,090,518.8 | 9,485,275.58 |
| 应收账款 | 77,031,669.37 | 92,851,291.92 | 88,667,030.89 | 103,940,669.17 |
| 应收款项融资 | 4,267,560 | 2,799,520 | 2,148,720 | 724,580 |
| 预付款项 | 109,510.99 | 167,018.99 | 681,029.07 | 89,629.5 |
| 其他应收款合计 | 2,311,804.55 | 2,321,688.8 | 2,175,857.96 | 2,370,437.65 |
| 存货 | 28,252,743.03 | 28,145,362.17 | 30,207,209.81 | 29,472,052.05 |
| 其他流动资产 | 426,435,529.19 | 403,600,475.54 | 382,249,735.96 | 401,846,947.89 |
| 流动资产合计 | 580,319,845.74 | 601,207,705.58 | 564,818,676.77 | 583,675,829.04 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 150,000 | 150,000 | 150,000 | 150,000 |
| 固定资产 | 157,941,648.75 | 165,256,048.98 | 172,677,923.1 | 173,148,832.65 |
| 在建工程 | 340,816.84 | 340,816.84 | 340,816.84 | 7,340,816.84 |
| 使用权资产 | 736,962.98 | 874,400.96 | 1,011,838.94 | 1,150,044.32 |
| 无形资产 | 12,617,844.35 | 13,346,985.35 | 14,076,126.35 | 14,646,933.35 |
| 长期待摊费用 | 1,411,226.97 | 226,666.46 | 262,455.95 | 298,245.44 |
| 递延所得税资产 | 201,538.22 | 521,100.73 | 339,323.34 | 107,034.24 |
| 其他非流动资产 | 9,665,265.31 | 7,086,974.55 | 6,752,495.13 | 7,284,400 |
| 非流动资产合计 | 183,065,303.42 | 187,802,993.87 | 195,610,979.65 | 204,126,306.84 |
| 资产总计 | 763,385,149.16 | 789,010,699.45 | 760,429,656.42 | 787,802,135.88 |
| 流动负债: | | | | |
| 短期借款 | - | 1,333,273.71 | - | 27,941,220.65 |
| 应付票据及应付账款 | 66,777,200.3 | 65,674,773.51 | 57,272,487.21 | 67,702,730.04 |
| 应付账款 | 66,777,200.3 | 65,674,773.51 | 57,272,487.21 | 67,702,730.04 |
| 预收款项 | - | - | 19,800 | - |
| 合同负债 | 15,118,415.28 | 18,720,948.07 | 20,094,991.01 | 21,829,351.97 |
| 应付职工薪酬 | 3,255,602.62 | 2,980,688.13 | 6,486,046.37 | 5,258,007.64 |
| 应交税费 | 1,089,919.32 | 1,085,739.45 | 985,155.83 | 2,938,891.45 |
| 其他应付款合计 | 18,088,941.87 | 18,352,203.48 | 4,194,546.02 | 2,677,329.79 |
| 一年内到期的非流动负债 | 613,305.49 | 603,314.04 | 593,437.75 | 583,681.08 |
| 其他流动负债 | 367,302.46 | 425,128.44 | 463,349.77 | 428,320.46 |
| 流动负债合计 | 105,310,687.34 | 109,176,068.83 | 90,109,813.96 | 129,359,533.08 |
| 非流动负债: | | | | |
| 租赁负债 | 195,457.96 | 359,781.03 | 512,357.94 | 662,317.29 |
| 递延收益 | 8,252,433.23 | 8,723,569.72 | 9,178,251.6 | 8,821,650 |
| 非流动负债合计 | 8,447,891.19 | 9,083,350.75 | 9,690,609.54 | 9,483,967.29 |
| 负债合计 | 113,758,578.53 | 118,259,419.58 | 99,800,423.5 | 138,843,500.37 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 273,350,000 | 273,350,000 | 273,350,000 | 273,350,000 |
| 资本公积 | 214,299,618.62 | 212,161,695.23 | 221,815,515.71 | 222,590,227.52 |
| 减:库存股 | 15,234,500 | 15,696,000 | 27,555,836.61 | 28,821,193.58 |
| 盈余公积 | 68,938,593.58 | 68,938,593.58 | 68,938,593.58 | 64,918,823.11 |
| 未分配利润 | 108,272,858.43 | 131,996,991.06 | 124,080,960.24 | 116,920,778.46 |
| 归属于母公司股东权益合计 | 649,626,570.63 | 670,751,279.87 | 660,629,232.92 | 648,958,635.51 |
| 股东权益合计 | 649,626,570.63 | 670,751,279.87 | 660,629,232.92 | 648,958,635.51 |
| 负债和股东权益合计 | 763,385,149.16 | 789,010,699.45 | 760,429,656.42 | 787,802,135.88 |
| 公告日期 | 2025-08-26 | 2025-04-28 | 2025-04-28 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |